Article
RyR1-related myopathy mutations in ATP and calcium binding sites impair channel regulation.
Acta neuropathologica communications - 22 Nov 2021
Yuan Qi, Dridi Haikel, Clarke Oliver B, Reiken Steven, Melville Zephan, Wronska Anetta, Kushnir Alexander, Zalk Ran, Sittenfeld Leah, Marks Andrew R
Abstract excerpt
The type 1 ryanodine receptor (RyR1) is an intracellular calcium (Ca2+) release channel on the sarcoplasmic/endoplasmic reticulum that is required for skeletal muscle contraction. RyR1 channel activity is modulated by ligands, including the activators Ca2+ and ATP. Patients with inherited mutations in RyR1 may exhibit muscle weakness as part of a heterogeneous, complex disorder known as RYR1-related myopathy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
